Back to Journals » Drug Design, Development and Therapy » Volume 13

Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways

Total article views   HTML views PDF downloads Totals
7,911 Dovepress* 6,380+ 1,011 7,391
PubMed Central* 1,531 411 1,942
Totals 7,911 1,422 9,333
*Since 2 December 2019

View citations on PubMed Central and Google Scholar